Orchestra BioMed Holdings (OBIO) Other Operating Expenses (2022 - 2026)

Orchestra BioMed Holdings (OBIO) has 5 years of Other Operating Expenses data on file, last reported at $1.4 million in Q1 2026.

• On a quarterly basis, Other Operating Expenses rose 734.34% year-over-year to $1.4 million in Q1 2026; TTM through Mar 2026 was $325000.0, a 86.91% decrease from a year earlier, with the FY2025 full-year figure at -$894000.0, down 127.28% from the prior year.
• Other Operating Expenses for Q1 2026 stood at $1.4 million, up from -$509000.0 in the prior quarter.
• Over the last five years, Other Operating Expenses for OBIO reached as high as $1.4 million in Q1 2026 and fell as low as -$601000.0 in Q1 2022.
• Historically, Other Operating Expenses has averaged $306058.8 across 5 years, with a median of $166000.0 in 2025.
• Across the five-year window, Other Operating Expenses sank 532.05% in 2023 and jumped 734.34% in 2026, its largest moves.
• Year by year, Other Operating Expenses stood at $78000.0 in 2022, then sank by 532.05% to -$337000.0 in 2023, then soared by 254.9% to $522000.0 in 2024, then sank by 197.51% to -$509000.0 in 2025, then surged by 372.1% to $1.4 million in 2026.
• Per Business Quant data, the three most recent Other Operating Expenses figures were $1.4 million in Q1 2026, -$509000.0 in Q4 2025, and -$515000.0 in Q3 2025.